Gland Pharma Limited has informed the Exchange regarding Appointment of Mr Jitendra Gangwal as Other of the company w.e.f. February 18, 2026.
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gland Pharma Limited has informed the stock exchange about the appointment of Mr Jitendra Gangwal to the company's board, effective February 18, 2026. The filing categorises him under the 'Others' category of directors. The announcement does not specify whether this is an independent, executive, or non-executive role. The full details of his designation and tenure would typically be available in the accompanying disclosure or the next corporate governance report. No additional context on who Mr. Gangwal is replacing or the rationale behind the appointment was provided in the headline.
This is a routine board-level appointment and is unlikely to cause any immediate movement in the stock price. Shareholders may want to review the detailed filing to understand Mr. Gangwal's background and the nature of his role on the board.